GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $257,000 | -3.7% | 5,892 | -2.8% | 0.05% | +1.9% |
Q4 2021 | $267,000 | +323.8% | 6,062 | +267.6% | 0.05% | +271.4% |
Q3 2021 | $63,000 | -19.2% | 1,649 | -14.5% | 0.01% | -17.6% |
Q2 2021 | $78,000 | +25.8% | 1,929 | +10.4% | 0.02% | +21.4% |
Q1 2021 | $62,000 | +82.4% | 1,748 | +90.0% | 0.01% | +75.0% |
Q4 2020 | $34,000 | +142.9% | 920 | +216.2% | 0.01% | +100.0% |
Q4 2019 | $14,000 | +16.7% | 291 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $12,000 | 0.0% | 291 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,000 | +200.0% | 291 | +191.0% | 0.00% | +100.0% |
Q4 2017 | $4,000 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |